Potential contributions of viral envelope and host genetic factors in a human immunodeficiency virus type 1-infected long-term survivor

被引:9
|
作者
Grovit-Ferbas, K
Ferbas, J
Gudeman, V
Sadeghi, S
Goetz, MB
Giorgi, JV
Chen, ISY
O'Brien, WA
机构
[1] Univ Calif Los Angeles, Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Sch Med, Dept Microbiol & Immunol, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, AIDS Inst, Los Angeles, CA 90095 USA
[4] Vet Adm Med Ctr, Los Angeles, CA 90073 USA
关键词
D O I
10.1128/JVI.72.11.8650-8658.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The Lack of clinical progression in some individuals despite prolonged human immunodeficiency virus type 1 (HIV-1) infection may result from infection with less-pathogenic viral strains. To address this question, we examined the IIIV-1 en;elope protein from a donor with a low viral burden, stable CD4(+) T-lymphocyte counts, and little evidence of CD8(+) T-cell expansion, activation, or immune activity. To avoid potential changes in envelope function resulting from selection in vitro, envelope clones were constructed by using viral RNA isolated from uncultured peripheral blood mononuclear cells (PBMC). The data showed that recombinant viruses containing envelope sequences derived from RNA isolated from patient PBMC replicated poorly in primary CD4(+) T cells but demonstrated efficient growth in macrophages. The unusual phenotype of these viruses could not be explained solely by differential utilization of coreceptors since the chimeric viruses, as well as an uncloned isolate obtained from the same visit date, can utilize CCR5. In addition, the donor's own cells appeared resistant to infection with chimeric viruses containing autologous envelope sequences. Genotype analysis revealed that the donor was heterozygous for the previously described 32-bp deletion in CCR5 which may be linked with prolonged survival in IIIV-1-infected individuals. These data suggest that the changes in envelope sequences confer properties of viral attenuation, which together with the CCR5 +/Delta 32 genotype could account for the long-term survival of this patient.
引用
收藏
页码:8650 / 8658
页数:9
相关论文
共 50 条
  • [1] DEFECTIVE ACCESSORY GENES IN A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED LONG-TERM SURVIVOR LACKING RECOVERABLE VIRUS
    MICHAEL, NL
    CHANG, G
    DARCY, LA
    EHRENBERG, PK
    MARIANI, R
    BUSCH, MP
    BIRX, DL
    SCHWARTZ, DH
    JOURNAL OF VIROLOGY, 1995, 69 (07) : 4228 - 4236
  • [2] Long-Term Control of Viral Replication in a Group O, Human Immunodeficiency Virus Type 1-Infected Individual
    Buckheit, Robert W., III
    Sexauer, Stephen B.
    Sedaghat, Ahmad R.
    Wilke, Claus O.
    Laeyendecker, Oliver
    Basseth, Christie R.
    Blankson, Joel N.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 (06) : 511 - 513
  • [3] Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors
    Bradney, AP
    Scheer, S
    Crawford, JM
    Buchbinder, SP
    Montefiori, DC
    JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (05): : 1264 - 1267
  • [4] Virologic and host characteristics of human immunodeficiency virus type 1-infected pediatric long term survivors
    Alexander, L
    Cuchura, L
    Simpson, BJ
    Andiman, WA
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (02) : 135 - 141
  • [5] Stability in controlling viral replication identifies long-term nonprogressors as a distinct subgroup among human immunodeficiency virus type 1-infected persons
    Vesanen, M
    Stevens, CE
    Taylor, PE
    Rubinstein, P
    Saksela, K
    JOURNAL OF VIROLOGY, 1996, 70 (12) : 9035 - 9040
  • [6] Role of the envelope genetic context in the development of enfuvirtide resistance in human immunodeficiency virus type 1-infected patients
    Labrosse, Beatrice
    Morand-Joubert, Laurence
    Goubard, Armelle
    Rochas, Severine
    Labernardiere, Jean-Louis
    Pacanowski, Jerome
    Meynard, Jean-Luc
    Hance, Allan J.
    Clavel, Francois
    Mammano, Fabrizio
    JOURNAL OF VIROLOGY, 2006, 80 (17) : 8807 - 8819
  • [7] Viral Tropism in Human Immunodeficiency Virus Type 1-Infected Children and Adolescents in Thailand
    Arayapong, Natt
    Pasomsub, Ekawat
    Kanlayanadonkit, Rujikorn
    Keatkla, Jiraporn
    Techasaensiri, Chonnamet
    Phuphuakrat, Angsana
    Sungkanuparph, Somnuek
    Apiwattanakul, Nopporn
    Chaisavaneeyakorn, Sujittra
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2021, 10 (01) : 1 - 6
  • [8] Long term tolerability and safety of enfuvirtide for human immunodeficiency virus 1-infected children
    Church, JA
    Hughes, M
    Chen, X
    Palumbo, P
    Mofenson, LM
    Delora, P
    Smith, E
    Wiznia, A
    Hawkins, E
    Sista, P
    Cunningham, CK
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (08) : 713 - 718
  • [9] Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine
    Jankelevich, S
    Mueller, BU
    Mackall, CL
    Smith, S
    Zwerski, S
    Wood, LV
    Zeichner, SL
    Serchuck, L
    Steinberg, SM
    Nelson, RP
    Sleasman, JW
    Nguyen, BY
    Pizzo, PA
    Yarchoan, R
    JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (07): : 1116 - 1120
  • [10] Memory responses in human immunodeficiency virus type 1-infected individuals with long-term viral load suppression are independent of CD4 cell nadir
    Kolber, MA
    Saenz, MO
    Kaul, S
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2005, 12 (01) : 76 - 80